fbpx

Alcon Expands Glaucoma Treatment Portfolio by Acquiring Transcend Medical

Alcon announced that it has entered into an agreement to acquire Transcend Medical, Inc., a privately-held, US-based company focused on developing minimally-invasive surgical devices to treat glaucoma.

Transcend Medical, Inc. has recently developed a micro-stent to treat mild to moderate glaucoma. The MIGS device is implanted just below the surface of the eye. It is designed to treat less severe glaucoma by enhancing part of the natural drainage pathways of the eye with minimal tissue disruption. This allows the excess fluid in the eye to drain with the goal of reducing intraocular pressure (IOP) levels.

“We expect the MIGS technology to be a great addition to our device pipeline and to establish Alcon’s presence in this new surgical category to treat glaucoma,” said Mike Ball, CEO of Alcon. “If approved, it will provide a less invasive means of lowering IOP than traditional invasive glaucoma surgery, with the goal of lowering the dependency of topical ocular medication. This acquisition also expands Alcon’s leadership in glaucoma and cataract treatment as part of our Surgical business.”

Featured Posts

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read More

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read More

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read More

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more